(64) designed and synthesized JAS239, a novel AfPIs targeting choline kinase alpha (ChoKα), and realized the goals of breast cancer imaging, antitumor therapy and monitoring choline metabolism in breast cancer. Here, CHKA is linked to breast carcinoma.